Ramírez MAJ, Sánchez GF, Méndez ARE, Vanda CB

Language: English/Spanish
References: 27
Page: 475-483
PDF size: 421.46 Kb.

ABSTRACT

Idiopathic pulmonary fibrosis (IPF) belongs to a group of multi-etiology, non-contagious, degenerative pulmonary diseases, which are known as interstitial pneumopathies in humans. They characteristically affect gas exchange at the pulmonary level, lower patient’s quality of life and have a bad prognosis. They are not frequent in domestic animals, thus they are usually not taken into account in clinical practice; and because definitive diagnosis requires histopathology, they are hardly recognized before the patient dies. The few animal cases described are very recent and not well known. Thus, the purpose of this article is to describe the clinical and pathological findings that characterize this disease, in a cat diagnosed at the Facultad de Medicina Veterinaria y Zootecnia de la Universidad Nacional Autonoma de Mexico.

REFERENCES

1. Crystal R, Gadek J, Ferrans V, Fulmer J, Line B, Hunninghake G. Interstitial lung disease. Current concepts of pathogenesis, staging and therapy. Am J Med 1981; 70:542-568.

2. Katzenstein AA, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18:136-147.

3. Colby TV. Pathologic spectrum and differential diagnosis of idiopathic interstitial pneumonias: In: American Thoracic Society. Idiopathic interstitial pneumonia: Current concepts and management. Postgraduate course. 1996 May 7-10, New Orleans: American Thoracic Society, 1996

4. Egan JJ, Woodcock AA. Does the treatment of cryptogenic fibrosing alveolitis influence prognosis? Respir Med 1996; 90:127-130.

5. Wallace WA, Lamb D. Cryptogenic fibrosing alveolitis: a clinico-pathological entity. Curr Diagn Pathol 1996; 3: 27-34.

6. Cotran RS, Kumar V, Robbins SL. Patología estructural y funcional. 5a ed. Madrid: Interamericana- McGraw-Hill, 1995.

7. Miller LG, Kazemi H. Manual clínico de neumología. México: McGraw-Hill; 1984: 239-275.

8. Crystal RG, Bitterman PB, Rennard SI, Hance A, Keog B. Interstitial lung diseases of unknown cause. N Engl J Med 1984; 310:154-166.

9. Tubbs R, Benjamin S, Reich N, McCormack L, Van Ordstrand S. Desquamative interstitial pneumonitis, cellular phase of fibrosing alveolitis. Chest 1977; 72: 159-166.

10. Winterbauer R, Hammar S, Hallman K, Hays J, Pardee N, Morgan E et al. Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. Am J Med 1978; 3:579-592.

11. Lobetti RG, Milner R, Lane E. Chronic idiopathic pulmonary fibrosis in five dogs. J Am Anim Hosp Assoc 2001; 37:119-27.

12. Rhind SM, Gunn-Moore DA. Desquamative form of cryptogenic fibrosing alveolitis in a cat. J Comp Pathol 2000; 123: 226-229.

13. Moses BL, Spaulding GL. Chronic bronchial disease of the cat. Vet Clin North Am Small Anim Pract 1985; 15: 929-947.

14. Bonagura JD, Hamlin RL, a Gaber CE. Chronic respiratory disease in the dog. In: Kirk RW, Bonagura JD, editors. Current Veterinary Therapy X. Philadelphia: Saunders Co, 1989: 361-368.

15. Corcoran BM, Cobb M, Martin MWS, Dukes-McEwans J, French A, Fuentes VL et al. Chronic pulmonary disease in West Highland White Terriers. Vet Rec 1999; 144:611-616.

16. Javaheri S, Sicilian L. Lung function, breathing pattern, and gas exchange in interstitial lung disease. Thorax 1992; 47:93-97.

17. Mariani TJ, Roby Jd, Mecham RP, Parks WC, Crouch E, Pierce RA. Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor- as a mediator of fibrosis. Am J Pathol 1996; 148:151-164.

18. Perez-Ramos J, Segura ML, Vanda B, Selman M, Pardo A. Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. Am J Respir Crit Care Med 1999; 160:1274-1282.

19. Silver RM, Warrick JH, Kinsella MB, Staudt LS, Baumann MH, Strange C. Cyclophosphamide and low dose prednisone therapy in patients with systemic sclerosis (scleroderma) with intrstitial lung disease. J Rheumatol 1993; 20:838-844.

20. Selman M, Chapela R, Montaño M, Soto H. Cambios en el contenido de colágena en diferentes enfermedades fibrosantes del pulmón. Arch Invest Med 1982; 13:93-100.

21. Leung AN, Miller RR, Müller NL. Parenchymal opacification in chronic infiltratiave lung diseases: CT-pathologic correlation. Radiology 1993; 188:209-214.

22. Nagai S, Aung H, Tanaka S, Satake N, Mio T, Kawatani A et al. Bronchoalveolar lavage findings in patients with BOOP and related disease. Chest 1992;102:325-375.

23. Raghu G. Idiopathic pulmonary fibrosis, a rational clinical approach. Chest 1987; 92:148-154.

24. Martínez D, Pérez J, Rojas A, Chapela R, Selman M. Vía aérea periférica y zona de transición en fibrosis pulmonar idiopática y alveolitis alérgica extrínseca. Neumol Cir Tórax 1984; 45:31-35.

25. Peters SG, McDougall Jc, Douglas WW, Coles DT, DeRemee RA. Colchicine in the treatment of pulmonary fibrosis. Chest 1993; 103:101-104.

26. Corcoran BM, Foster DJ, Fuentes VL. Feline asthma syndrome. J Small Anim Pract 1995; 36:481-488.

27. Suter PF, Lord PF. Thoracic radiograph. A text atlas of thoracic diseases of the dog and cat. Switzerland: Suter PF, 1984